Celularity (CELUW) Interest & Investment Income (2019 - 2021)
Celularity (CELUW) reported Interest & Investment Income of $9175.0 for Q2 2021, down 98.16% year-over-year from $497975.0 in Q2 2020, and down 67.09% quarter-over-quarter from $27883.0 in Q1 2021.
Celularity (CELUW) Interest & Investment Income (2019 - 2021) Analysis & Trends
Celularity (CELUW) has 3 years of Interest & Investment Income data on file, last reported at $9175.0 in Q2 2021.
- Interest & Investment Income for Q2 2021 came in at $9175.0, down 98.16% year-over-year; the trailing twelve-month figure through Jun 2021 was $635762.0 (down 86.44% YoY), and the FY2019 annual result was $3.8 million, changed N/A from the prior year.
- Interest & Investment Income retreated to $9175.0 in Q2 2021 per CELUW's latest filing, from $27883.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.7 million in Q3 2019 and troughed at $9175.0 in Q2 2021.
- A 3-year average of $687281.0 and a median of $584984.0 in 2019 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2020 and 2021: Interest & Investment Income fell 25.9% in 2020, then slumped 98.16% in 2021.
- A 3-year view of Interest & Investment Income shows it stood at $1.4 million in 2019, then sank by 92.81% to $100729.0 in 2020, then sank by 90.89% to $9175.0 in 2021.
- Business Quant data shows CELUW's Interest & Investment Income at $9175.0 in Q2 2021, $27883.0 in Q1 2021, and $100729.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Celularity | - | - | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 9,175.00 |
| Mar 31, 2021 | 27,883.00 |
| Sep 30, 2020 | 100,729.00 |
| Jun 30, 2020 | 497,975.00 |
| Mar 31, 2020 | 1.11 Mn |
| Dec 31, 2019 | 1.40 Mn |
| Sep 30, 2019 | 1.68 Mn |
| Jun 30, 2019 | 671,993.00 |